JD
Jaikrishan Dwarikanath Kotru
About Jaikrishan Dwarikanath Kotru
Data last updated:
Jaikrishan Dwarikanath Kotru is a Director at Novo Pharm Formulations Private Limited (since 2015) and Director at Esbamax Global Alliance Private Limited (since 2022). The companies operate in Pharma and Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹3.67 Cr; the largest is Novo Pharm Formulations Private Limited at ₹3.01 Cr (FY 2025). Earlier, Jaikrishan Dwarikanath Kotru was a Director at Shalmax Global Alliance Private Limited (from 2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novo Pharm Formulations Private Limited U24231GJ1995PTC025060 | Director | 27 Mar 2015 | 1995 | ₹3.01 Cr (FY 2025) | Active |
 Esbamax Global Alliance Private Limited U51909GJ2022PTC135994 | Director | 07 Oct 2022 | 2022 | ₹65.4 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Shalmax Global Alliance Private Limited U24299GJ2018PTC104928 | Director | 25 Oct 2018 | 2018 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Jaikrishan Dwarikanath Kotru
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dhwani Ojas Patel | 09431110 | Novo Pharm Formulations Private Limited | Director |
| Ojasbhai Ravjibhai Patel | 01763528 | Novo Pharm Formulations Private Limited | Director |
| Ravjibhai Ashabhai Patel | 03468857 | Novo Pharm Formulations Private Limited | Director |
| Snehlata Jaikrishan Kotru | 09758854 | Esbamax Global Alliance Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jaikrishan Dwarikanath Kotru
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jaikrishan Dwarikanath Kotru
Jaikrishan Dwarikanath Kotru currently holds 2 directorships: Novo Pharm Formulations Private Limited (Director, since 27 Mar 2015, revenue ₹3.01 Cr (FY 2025)); Esbamax Global Alliance Private Limited (Director, since 07 Oct 2022, revenue ₹65.4 Lakh (FY 2025)).
Jaikrishan Dwarikanath Kotru was first appointed on 27 Mar 2015 as Director at Novo Pharm Formulations Private Limited. The most recent appointment on record is 07 Oct 2022 at Esbamax Global Alliance Private Limited.
The 2 current companies of Jaikrishan Dwarikanath Kotru that report revenue have a combined latest revenue of ₹3.67 Cr: Novo Pharm Formulations Private Limited ₹3.01 Cr (FY 2025); Esbamax Global Alliance Private Limited ₹65.4 Lakh (FY 2025).
Jaikrishan Dwarikanath Kotru held 1 earlier board appointment: Shalmax Global Alliance Private Limited (Director, from 25 Oct 2018).
The current boards of Jaikrishan Dwarikanath Kotru's companies include Dhwani Ojas Patel (Novo Pharm Formulations Private Limited), Ojasbhai Ravjibhai Patel (Novo Pharm Formulations Private Limited), Ravjibhai Ashabhai Patel (Novo Pharm Formulations Private Limited), Snehlata Jaikrishan Kotru (Esbamax Global Alliance Private Limited).